Lawrence OB/GYN Clinical Research, LLC   Report issue

For profit Phase 3
Founded: Lawrenceville NJ United States (2010)

Organization Overview

First Clinical Trial
2014
NCT02195986
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

estradiol (progynon depot) (1 trial)

estrogen (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrophic Vaginitis (Phase 3)

Atrophy (Phase 3)

Vaginitis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2